Indication

Lymphoid Neoplasm

1 clinical trial

1 product

Clinical trial

Phase II Clinical Trial of Flu-Bu-Mel-E (Fludarabine, Busulfan, Melphalan and Etoposide) as Conditioning Regimen for Patients With Lymphoid Malignancies Undergoing Allogeneic Stem Cell Transplantation

Status: Recruiting, Estimated PCD: 2024-06-01

Product